Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Director's Interest

15 Oct 2010 16:32

RNS Number : 5056U
Pressure Technologies PLC
15 October 2010
 



 

Pressure Technologies PLC

 

("Pressure Technologies" or the "Company")

 

Director's Interest

 

Pressure Technologies was informed on 8 October 2010 by Brewin Dolphin Limited ("BDL") that as of 7 October 2010 it held an indirect interest in 119,005 ordinary shares of the Company representing 1.05% of the issued ordinary share capital and voting rights of the Company. The indirect interests are in 49,984 ordinary shares held by Brewin Nominees Limited and 69,021 ordinary shares held by Giltspur Nominees Limited. Prior to the notification above, BDL had an interest in 1,130,471 ordinary shares of Pressure Technologies, representing 9.97% of the issued ordinary share capital and voting rights of the Company.

 

Of the previous interest of BDL referred to above, 1,000,040 ordinary shares, representing 8.82% of the issued ordinary share capital and voting rights of the Company, were held and continue to be held on behalf of John Hayward, the Chief Executive Officer of Pressure Technologies. The change of BDL's interest has arisen because certain shareholdings (including John Hayward's shareholding) are now held on an advisory basis rather than a discretionary basis by BDL. For the sake of clarity, John Hayward's beneficial interest in the share capital of the Company, being 1,000,040 ordinary shares representing 8.82% of the issued share capital of the Company, remains unchanged by this event.

 

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax IS PLC

Ewan Leggat/Simon Bennett

 

Tel: 0207 598 5368 

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is the holding company for Chesterfield Special Cylinders Limited ("CSC"). CSC designs, manufactures and offers retesting and refurbishment services for a range of speciality high-pressure, seamless steel gas cylinders for global energy and defence markets. The business has been conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas ("CBG"), an operating division of Pressure Technologies, formed in November 2008 following the signing of a co-operation agreement with Greenlane Biogas Limited, the world leader in biogas upgrading from raw biogas to vehicle quality fuel, gives Pressure Technologies exclusive rights to market Greenlane equipment in the UK and Eire. Chesterfield BioGas will provide turnkey solutions for the cleaning, storage and dispensing of biomethane, produced from waste water treatment and anaerobic digestion of organic waste.

 

Al-Met Limited ("Al-Met"), which was acquired by the Group in February 2010, is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, based in Pontyclun, near Cardiff. Al-Met's products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, established in 1985, has developed a leading edge capability in precision machining carbides and superalloy matrix materials. The ability to combine high alloy steels with tungsten carbide inserts and specialised coatings gives Al-Met its niche position with its customers, global wellhead and subsea equipment OEMs.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASESFDAEFFF
Date   Source Headline
16th Oct 20174:35 pmRNSPrice Monitoring Extension
16th Oct 20173:00 pmRNSResult of Oversubscribed Placing
16th Oct 20178:00 amRNSProposed Placing
21st Sep 201712:24 pmRNSHolding(s) in Company
31st Aug 20177:00 amRNSTrading Update
13th Jun 20177:00 amRNSHalf-year Report
30th Mar 20173:47 pmRNSDirector Declaration
16th Mar 20171:28 pmRNSExercise of Options
27th Feb 20173:16 pmRNSDirector/PDMR Shareholding
16th Feb 201712:42 pmRNSExercise of Options
14th Feb 20171:08 pmRNSResult of AGM
31st Jan 201710:19 amRNSExercise of Options
6th Jan 20179:25 amRNSNotice of AGM
22nd Dec 201610:25 amRNSPublication of Annual Report
13th Dec 20167:00 amRNS2016 Audited Preliminary Results
8th Dec 20167:00 amRNSAcquisition of Martract Limited
6th Dec 201610:11 amRNSNotice of Results
23rd Nov 20169:49 amRNSChange of Registrar
11th Oct 20162:09 pmRNSGrant of Share Options
10th Oct 20161:40 pmRNSNotice to Shareholders in accordance with FRS 101
30th Aug 20167:00 amRNSUpdate on Recent Trading
3rd Aug 20164:27 pmRNSGrant of Share Options
14th Jun 20167:00 amRNSHalf-year Report
27th Apr 20167:00 amRNSUpdate on Recent Trading
2nd Mar 20162:05 pmRNSExercise of Options
17th Feb 20161:14 pmRNSResult of AGM
17th Feb 20167:00 amRNSAGM Statement
11th Feb 20167:00 amRNSUpdate on investigation into fatality
26th Jan 20161:45 pmRNSCapital Markets Day
22nd Jan 20163:42 pmRNSIssue of Equity
15th Jan 201610:50 amRNSIssue of Equity
8th Jan 20163:05 pmRNSPublication of Annual Report and Notice of AGM
23rd Dec 20157:00 amRNSGrant of Share Options
23rd Dec 20157:00 amRNSExercise of Options
15th Dec 20157:00 amRNSFinal Results
17th Nov 20157:00 amRNSExercise of Options
10th Nov 20157:00 amRNSFull Year Trading Update
5th Oct 201510:22 amRNSHolding(s) in Company
5th Oct 20157:00 amRNSDirector Shareholding
1st Oct 20155:20 pmRNSExercise of Options
29th Sep 20152:30 pmRNSExercise of Options
11th Sep 20157:00 amRNSEXERCISE OF OPTIONS
2nd Sep 20157:00 amRNSIssue of Equity
27th Aug 20157:01 amRNSDirectorate Change
30th Jul 20151:18 pmRNSGrant of Share Options
25th Jun 20154:00 pmRNSGrant of Share Options
16th Jun 20157:01 amRNSDirectorate Change
16th Jun 20157:00 amRNSHalf Yearly Report
15th Jun 20157:00 amRNSChange of Adviser
4th Jun 20157:00 amRNSUpdate on Trading and Notice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.